At-Home LED and Laser Skin Devices (Blue Light Acne, Red Light Collagen, IPL — Eye Safety, Photosensitizing Drug Interactions) — household safety profile
Moderate riskAt-home LED and laser skin devices have grown into a $1.1 billion global market (2023), with devices delivering blue light (415nm, targeting P.
What is this product?
At-home LED and laser skin devices have grown into a $1.1 billion global market (2023), with devices delivering blue light (415nm, targeting P. acnes bacteria), red light (630-660nm, promoting collagen synthesis), near-infrared (830-850nm, anti-inflammatory), and IPL (intense pulsed light, 500-1200nm, hair removal and pigmentation). FDA classifies most at-home LED devices as Class II medical devices requiring 510(k) clearance, but enforcement is inconsistent — dozens of uncleared devices are available on Amazon and direct-to-consumer channels. Key safety concerns include: (1) Eye damage — LED devices operating at 630-850nm can cause retinal damage at irradiances above 10 mW/cm2, with IEC 62471 photobiological safety limits often not referenced in consumer device manuals; (2) Photosensitizing drug interactions — patients on doxycycline, retinoids (tretinoin, isotretinoin), fluoroquinolones, thiazide diuretics, or NSAIDs (piroxicam) face increased risk of phototoxic reactions, burns, and hyperpigmentation from LED/IPL devices; (3) At-home IPL devices deliver fluences of 3-7 J/cm2 (vs. 15-40 J/cm2 clinical) — lower risk but unregulated use without skin type assessment (Fitzpatrick V-VI contraindicated for IPL) causes burns. A 2022 JAMA Dermatology review found that 37% of at-home device adverse events reported to FDA MAUDE were burns, and 18% were eye injuries.
What's in it
Click any compound name for its full safety profile, regulatory consensus, and exposure data.
Component Material
Frequently asked questions
No FAQs generated.
Look up At-Home LED and Laser Skin Devices (Blue Light Acne, Red Light Collagen, IPL — Eye Safety, Photosensitizing Drug Interactions) in the home app
Search by ingredient, browse by category, or compare to alternatives in the live app.
Open in home View raw API dataReference data, not professional advice. Aggregates publicly available regulatory and scientific information. Why we built ALETHEIA →